<DOC>
	<DOCNO>NCT00973024</DOCNO>
	<brief_summary>The purpose study compare safety effectiveness different dose JNJ-42160443 placebo treatment chronic , moderate severe low back pain patient diagnosis chronic low back pain .</brief_summary>
	<brief_title>A Dose-ranging Study Safety Effectiveness JNJ-42160443 add-on Treatment Patients With Low Back Pain</brief_title>
	<detailed_description>This randomize ( study drug assign chance ) , double-blind ( neither physician patient know name assign drug ) study evaluate safety effectiveness different dose JNJ-42160443 compare placebo treatment patient diagnosis chronic low back pain moderate severe , chronic low back pain control standard pain medication . JNJ-42160443 ( 10 mg/ml ) match placebo give subcutaneous ( SC ) ( skin ) injection ( inj ) every 4 week ( wks ) ; one four JNJ-42160443 dos ( 1 mg every 4 wks ; 3 mg every 4 wks ; 6 mg load dose Day 1 follow 3 mg every 4 wks ; 10 mg every 4 wks , match placebo 104 wks ( 12-wk double-blind efficacy period + 92-wk double-blind extension period ) .</detailed_description>
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Low Back Pain</mesh_term>
	<criteria>Diagnosis chronic low back pain Pain radiation extremity neurologic sign history within past year following : seizure disorder intrathecal therapy ventricular shunt , mild moderate traumatic brain injury , stroke , transient ischemic attack , meningitis History brain injury within past 15 year consist &gt; = 1 follow , residual sequalae suggest transient change consciousness : brain contusion , intracranial hematoma , either unconsciousness posttraumatic amnesia last 24 hour History epilepsy multiple sclerosis Current diagnosis fibromyalgia , complex regional pain syndrome ( include reflex sympathetic dystrophy causalgia ) , acute spinal cord compression , bowel bladder dysfunction result cauda equine compression , back pain cause secondary infection , pain cause confirm suspected neoplasm Any new unresolved neurologic deficit , include progressive deficit , within 6 month screen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>JNJ-42160443</keyword>
	<keyword>Low back pain-related pain</keyword>
	<keyword>moderate severe , chronic pain</keyword>
</DOC>